Top RFK Jr. Aide Attacks US Health System While Running Company That Promotes Wellness Alternatives

C-SPAN via AP
In this image from video provided by C-SPAN, Calley Means, a key adviser to Health and Human Services Secretary Robert F. Kennedy Jr., speaks during a news conference where the HHS and FDA announced plans to ban petroleum-based food dyes, in Washington, on April 22, 2025.
WASHINGTON (AP) — Calley Means has built a following within the 'Make America Healthy Again' movement by railing against the failings of the U.S. health system, often pinning the blame on one issue: corruption.
Means, a top aide to Health Secretary Robert F. Kennedy Jr., was hired as a White House adviser in March. He has used that perch to attack the nation's leading physician groups, federal agencies and government scientists, claiming they only protect their own interests in the nation's $4.9 trillion-a-year industry.
In recent interviews, speeches and podcasts he has called the American Medical Association 'a pharma lobbying group,' labeled the Food and Drug Administration 'a sock puppet of industry,' and said federal health scientists have 'overseen a record of utter failure.'
Means, however, has his own financial stake in the sprawling health system. He's the co-founder of an online platform, Truemed, that offers dietary supplements, herbal remedies and other wellness products. Some of the vendors featured on Truemed's website are supporters of Kennedy's MAHA movement, which downplays the benefits of prescription drugs, vaccines and other rigorously tested medical products.
Kennedy has pledged to run the Department of Health and Human Services with 'radical transparency,' but Means has never had to publicly disclose his own financial details or where exactly they intersect with the policies he's advancing.
'It reeks of hypocrisy,' said Dr. Reshma Ramachandran, a health researcher at Yale University. 'In effect, he is representing another industry that is touting nonregulated products and using his platform within the government to financially benefit himself.'
In a written statement, Means said his government work has not dealt with matters affecting Truemed and has focused on issues like reforming nutrition programs and pressuring companies to phase out food dyes.
'Pursuing these large-scale MAHA goals to make America healthy has been the sole focus in my government work,' Means said.
Truemed helps users take tax-free money out of their health savings accounts, or HSAs, to spend on things that wouldn't normally qualify as medical expenses, such as exercise equipment, meal delivery services and homeopathic remedies — mixtures of plants and minerals based on a centuries-old theory of medicine that's not supported by modern science.
The business model caught the attention of the IRS last year, which issued an alert: 'Beware of companies misrepresenting nutrition, wellness and general health expenses as medical care.'
Truemed co-founder and CEO, Justin Mares, said in a statement the company is 'in full alignment' with IRS guidelines.
'Truemed enables patients to work with providers to use medical funds for root cause interventions like exercise and vitamin D to reverse disease under current law,' Mares said.
The full extent of Means' potential conflicts — including his personal investments— are unclear because of his status as a special government employee.
Unlike presidential appointees and other senior officials, special government employees are temporary staffers who do not have to leave companies or sell investments that could be impacted by their work. Also, their financial disclosure forms are shielded from public release.
'It's a big problem,' says Richard Painter, a former White House ethics lawyer under George W. Bush now at the University of Minnesota. Painter and other experts have raised alarms over a whirlwind of Trump administration actions to dismantle the government's public integrity guardrails.
Still, part-time government employees are subject to the same law that bars all federal staffers from working on issues that could directly benefit their finances. When such cases arise, they must recuse themselves or risk criminal penalties.
Means regularly opines on matters before HHS, including rethinking the use of drugs for depression, weight loss, diabetes and other conditions. Recently he's been promoting a new government report that calls for scaling back prescription medications in favor of exercise, dietary changes and other alternatives.
'If we rely less on our medical system, less on drugs, it necessitates the spiritual, cultural conversation about what we're doing to our children's bodies,' Means said in a recent podcast appearance.
Experts note that government ethics rules are intended to both prevent financial conflict violations, but also the appearance of such conflicts that might undermine public trust in government.
'If I were running the ethics office over at HHS, I sure as heck wouldn't want anybody going around giving interviews and speeches about government matters that could have an effect on their own financial interests,' Painter said.
A rising star in the MAHA movement
Means' rapid rise reflects the seeming contradictions within the MAHA movement itself, which urges followers to distrust both big corporations and the government agencies which regulate them.
Means rails against big pharma and food conglomerates, two industries that he says he spent years working for as a consultant in Washington.
Means has no medical training. A graduate of Harvard Business School, he previously ran a bridal gown startup with his wife. On Wednesday, he's scheduled to be the keynote speaker at FDA's annual science forum, according to a copy of the program shared with The Associated Press.
He traces his passion for health care reform to the death of his mother from pancreatic cancer in 2021. Shortly thereafter, Means and his sister, Dr. Casey Means, took psychedelics together and had 'a mind-blowing, life-changing experience,' which led them to co-author a wellness book, launch separate health startups and begin appearing on podcasts.
Casey Means was recently nominated to be surgeon general and has faced scrutiny over her qualifications, including an unfinished medical residency.
Asked about her nomination, President Donald Trump said: 'Bobby thought she was fantastic,' adding that he did not know her.
Meanwhile, her brother has stepped up his rhetoric for the MAHA agenda, recently declaring that Kennedy has 'a spiritual mandate to reform our broken system.'
While promoting the administration's accomplishments, Means does not shy away from plugging his own brand or those of his business partners.
When asked to offer health advice to listeners of a sports podcast, Outkick The Show, in April, Means said: 'Read our book, 'Good Energy.''
He also recommended blood tests sold by Function Health, which provides subscription-based testing for $500 annually. The company was cofounded by Dr. Mark Hyman, a friend of Kennedy and an investor in Truemed, which also offers Hyman's supplements through its platform. Casey Means is also an investor in Hyman's company.
'If you're sick, most likely you have some kind of nutrient deficiency, some kind of biomarker that you can actually then target with your diet and your supplements,' Calley Means said.
Like dietary supplements, the marketing claims on laboratory tests sold by Hyman are not approved by the FDA. The agency has warned for years about the accuracy of such tests and tried to start regulating them under President Joe Biden.
Experts say MAHA entrepreneurs like Hyman are following a playbook common to the wellness industry: Identify a health concern, market a test to diagnose it and then sell supplements or other remedies to treat it.
'It ends up favoring these products and services that rest on flimsy grounds, at the expense of products that have actually survived a rigorous FDA approval process,' said Dr. Peter Lurie, a former FDA official who is now president of the Center for Science in the Public Interest.
Many of the items sold via Truemed, including sweat tents, cold plunge tanks and light therapy lamps, wouldn't typically qualify as medical expenses under rules for HSAs, tax-free accounts created by Congress to manage medical costs.
The IRS generally states that HSA purchases must help diagnose, cure, treat, mitigate or prevent disease.
Truemed allows users to request a 'letter of medical necessity' from a doctor, stating that the product in question could have medical value for them. Like other telehealth services, there's usually no real-time communication with the patient. The physician reviews a 'simple survey solution,' filled out by the Truemed user, according to the company's website.
Industry representatives say customers should be careful.
'You need to be prepared to defend your spending habits under audit,' said Kevin McKechnie, head of the American Bankers Association's HSA council. 'Companies are popping up suggesting they can help you manage that process and maybe they can — so the debate continues.'
Americans have an estimated $147 billion in HSA accounts, a potential windfall for companies like Truemed that collects fees for transactions made using their platforms.
Means sees an even bigger opportunity — routing federal funds out of government programs and into more HSAs.
'The point of our company is to steer medical dollars into flexible spending,' Means told fitness celebrity Jillian Michaels, on her podcast last year. 'I want to get that $4.5 trillion of Medicare, Medicaid, everything into a flexible account.'
Who benefits most from HSAs?
Means' pitch for expanding HSAs echoes two decades of Republican talking points on the accounts, which were created in 2003 to encourage Americans in high-deductible plans to be judicious with their health dollars.
But HSAs have not brought down spending, economists say. They are disproportionately used by the wealthiest Americans, who have more income to fund them and a bigger incentive to lower their tax rate.
Americans who earn more than $1 million annually are the group most likely to make regular HSA contributions, according to an analysis by the nonprofit Center on Budget and Policy Priorities. More than half Americans with HSAs have balances less than $500.
Trump's 'One Big Beautiful Bill' would further expand HSA purchases, making gym memberships and other fitness expenses eligible for tax-free spending. That provision alone is expected to cost the government $10 billion in revenue.
'These are really just tax breaks in the guise of health policy that overwhelmingly benefit people with high incomes,' said Gideon Lukens, a former White House budget official during the Obama and Trump administrations, now with the Center on Budget and Policy Priorities.
Expanding HSA eligibility was listed as a goal for a coalition of MAHA entrepreneurs and Truemed partners, founded by Means, which lobbied Congress last year, according to the group's website.
Means said in a statement that the group focused only on broad topics like 'health care incentives and patient choice — but did not lobby for specific bills.'
In total, the HSA expansions in Trump's bill are projected to cost the federal government $180 billion over the next 10 years. As HSAs expand to include more disparate products and services, Lukens says the U.S. government will have fewer dollars to expand medical coverage through programs like Medicaid.
'We have a limited amount of federal resources and the question is whether we want to spend that on health and wellness products that may or may not be helpful for wealthy people,' Lukens said.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Nikkei Asia

4 hours ago

• Nikkei Asia

Columbia University protester Mahmoud Khalil freed from detention

Palestinian activist Mahmoud Khalil speaks after his release from federal immigration detention in Jena, Louisiana on June 20. © AP JENA, Louisiana (AP) -- Palestinian activist Mahmoud Khalil was released Friday from federal immigration detention, freed after 104 days by a judge's ruling after becoming a symbol of President Donald Trump 's clampdown on campus protests. The former Columbia University graduate student left a federal facility in Louisiana on Friday. He is expected to head to New York to reunite with his U.S. citizen wife and infant son, born while Khalil was detained.

Yomiuri Shimbun

6 hours ago

• Yomiuri Shimbun

UK Lawmakers Back a Bill to Allow Terminally Ill Adults to End Their Lives

LONDON (AP) — U.K. lawmakers on Friday approved a bill to allow terminally ill adults in England and Wales to choose to end their lives, taking it one step nearer to becoming law. The vote backing what is generally termed ' assisted dying ' — sometimes referred to as 'assisted suicide' — is potentially the biggest change to social policy in the U.K. since abortion was partially legalized in 1967. Members of Parliament voted 314-291 to back the Terminally Ill Adults (End of Life) Bill following an impassioned debate. The majority of 23 was less than the 55 when they last voted on the issue in November, meaning that some lawmakers changed their minds in the intervening months. Since November, the bill has been scrutinized, leading to some changes in the proposed legislation, which has been shepherded through Parliament by Kim Leadbeater, the Labour lawmaker who proposed the bill. 'I appreciate it's a huge moment for the country,' she told Sky News after the vote. 'It was a huge sense of relief because this is the right thing to do.' The bill now goes to the unelected House of Lords, which can amend or delay policy, though it can't overrule the lower chamber. What lawmakers voted on The bill would allow terminally ill adults over age 18 in England and Wales, who are deemed to have less than six months to live, to apply for an assisted death. The bill doesn't apply to Northern Ireland or Scotland, which is holding its own vote on the issue. One of the most important changes to the bill from last November was the dropping of the requirement that a judge sign off on any decision. Many in the legal profession had objected. Now any request would be subject to approval by two doctors and a panel featuring a social worker, senior legal figure and psychiatrist. Changes were also made to ensure the establishment of independent advocates to support people with learning disabilities, autism or mental health conditions and the creation of a disability advisory board. After receiving a go-ahead from doctors and the panel, the terminally ill person would have to be capable of taking the fatal drugs themselves. Another big change made was that 'no person,' including doctors, social care workers and pharmacists, will be obliged to take part. Divisive issue The bill has divided lawmakers for months. The vote was a free one, meaning lawmakers vote according to their conscience rather than on party lines. Alliances have formed across the political divide. Proponents of the bill argued that those with a terminal diagnosis must be given a choice at the end of their lives to relieve their suffering. They also said that the current situation discriminates against the poor as wealthy individuals can already travel to Switzerland, which allows foreigners to legally end their lives, while others have to face possible prosecution for helping their loved ones die. However, opponents warned that the most vulnerable in society, such as disabled and older people, could be at risk of being coerced, directly or indirectly, into ending their lives to save money or relieve the burden on family members. Both sides agreed on the need to make improvements in palliative care and greater investments in hospices to ease suffering. Passions ran high outside of Parliament where hundreds of people gathered to make their voices heard. Supporters were dressed in clothing emblazoned with the phrase 'Campaign for Dignity in Dying,' while opponents held up banners urging lawmakers not to make the state-run National Health Service the 'National Suicide Service.' Supporters wept, jumped and hugged each other as the bill was backed. 'This is for all the people who couldn't be here today,' said Sarah Wootton, chief executive of Dignity in Dying. 'This vote sends a clear message. Parliament stands with the public and change is coming.' Timeline for the bill The legislation now goes to the unelected House of Lords. Any amendments would then go back to the House of Commons. There's also the possibility of legal challenge to the policy. Opposition campaigners such as 'Right To Life U.K.' and 'Care Not Killing' said after the vote that they weren't giving up the fight. Backers of the bill say implementation will take four years, rather than the initially suggested two. That means it could become law in 2029, around the time that the next general election must be held. Government stance There is clearly no consensus in the Cabinet about the measure. Prime Minister Keir Starmer backed the bill on Friday, while his health secretary, Wes Streeting, voted against. The government has said it will respect the outcome. However, it's not clear what the cost implications are, or how it would impact the NHS, hospice care and the legal system. Nations where assisted dying is legal Other countries that have legalized assisted suicide include Australia, Belgium, Canada and parts of the United States, with regulations on who is eligible varying by jurisdiction. Assisted suicide is different from euthanasia, allowed in the Netherlands and Canada, which involves health care practitioners administering a lethal injection at the patient's request in specific circumstances.

Yomiuri Shimbun

6 hours ago

• Yomiuri Shimbun

Europeans' Meeting with Top Iranian Diplomat Yields Hope of More Talks but No Breakthrough

GENEVA (AP) — A meeting between Iran's foreign minister and top European diplomats on Friday yielded hopes of further talks but no immediate concrete breakthrough, a week after the crisis centered on the Iranian nuclear program erupted into war between Israel and Tehran. Foreign ministers from Britain, France and Germany, as well as the European Union's foreign policy chief, emerged from talks at a Geneva hotel about 3 1/2 hours after Iran's Abbas Araghchi arrived for the meeting. It was the first face-to-face meeting between Western and Iranian officials since the start of the conflict. In a joint written statement issued after the talks ended, the three European nations and the EU said that they 'discussed avenues towards a negotiated solution to Iran's nuclear program.' They reiterated their concerns about the 'expansion' of the nuclear program, adding that it has 'no credible civilian purpose.' 'The good result today is that we leave the room with the impression that the Iranian side is fundamentally ready to continue talking about all important issues,' German Foreign Minister Johann Wadephul said, adding both sides had held 'very serious talks.' British Foreign Secretary David Lammy said: 'We are keen to continue ongoing discussions and negotiations with Iran, and we urge Iran to continue their talks with the United States.' He added that 'we were clear: Iran cannot have a nuclear weapon.' In a separate statement, Lammy stressed that the aim of Europe and the U.S. was that Iran should stop all uranium enrichment. He said that 'there can be discussions about the energy needs of Iran' but added that 'zero enrichment is the starting point.' Lammy told British media outlets that there is 'a window of within two weeks where we can see a diplomatic solution,' and urged Iran 'to take that off ramp.' 'We must absolutely prioritize a return to full negotiations that include the nuclear program to go toward zero enrichment,' said French President Emmanuel Macron earlier on Friday in an apparent alignment with the U.S. position. Enrichment has been the key point of contention in talks between the U.S. and Iran over its nuclear program. U.S. Mideast envoy Steve Witkoff at one point suggested Iran could enrich uranium at 3.67%, then later began saying Iran must stop all enrichment on its soil. That position on the American side has hardened over time. Tehran rejects giving up all uranium enrichment. 'Military operations can slow Iran's nuclear program but in no way can they eliminate it,' said French Foreign Minister Jean-Noël Barrot. 'We know well — after having seen what happened in Afghanistan, in Iraq, in Libya — how illusory and dangerous it is to want to impose regime change from outside.' Barrot also said that European nations 'invited the Iranian minister to envisage negotiations with all parties including the United States, and without waiting for the end of the strikes.' The French Foreign Minister explained that in discussions with Iran, Foreign Minister Araghchi agreed 'to put all the issues on the table including some that weren't there before' and 'showed his disposition to continuing the conversation — that we started today — and for the Europeans to help facilitate, including with the United States.' EU foreign policy chief Kaja Kallas said 'we agreed that we will discuss nuclear but also broader issues that we have, and keep the discussions open.' Iran's Foreign Minister Abbas Araghchi also addressed reporters outside the meeting venue after the talks ended. He expressed support for continuing discussions with the three European countries and the EU. He also denounced Israel's attacks against nuclear facilities in Iran and expressed 'grave concern' over what he called 'non-condemnation' by European nations. U.S. considering how to proceed Lammy traveled to Geneva after meeting in Washington with U.S. Secretary of State Marco Rubio and President Donald Trump's Mideast envoy, Steve Witkoff. Trump has been weighing whether to attack Iran by striking its well-defended Fordo uranium enrichment facility, which is buried under a mountain and widely considered to be out of reach of all but America's 'bunker-buster' bombs. He said Wednesday that he'll decide within two weeks whether the U.S. military will get directly involved in the war given the 'substantial chance' for renewed negotiations over Tehran's nuclear program. Israel says it launched its airstrike campaign to stop Iran from getting closer to being able to build a nuclear weapon. Iran and the United States had been negotiating over the possibility of a new diplomatic deal over Tehran's program, though Trump has said Israel's campaign came after a 60-day window he set for the talks. French Foreign Minister Jean-Noël Barrot said that 'we wanted to open a discussion with the Iranian foreign minister because we believe that there is no definitive solution by military means to the Iranian nuclear problem — military operations may delay it but they can't eliminate it.' 'We are not seeking negotiations' Iran's supreme leader rejectedU.S. calls for surrender Wednesday and warned that any military involvement by the Americans would cause 'irreparable damage to them.' Before Friday's talks, Araghchi said in an interview aired by Iranian state television that 'in the current situation, as the Zionist regime's attacks continue, we are not seeking negotiations with anyone.' He said that 'we have nothing to discuss with the United States, which is a partner in these crimes.' 'As for others, if they seek dialogue, not negotiations, which don't make sense right now, we have no problem with that,' he added. He said that Friday's discussion would focus 'solely on the nuclear issue and regional matters' and Iran won't hold talks on its missiles with anyone. Threats to reinstate sanctions Just before meeting the European diplomats, Araghchi made a brief appearance before the U.N. Human Rights Council in Geneva. He said that Israel's 'attacks on nuclear facilities are grave war crimes,' and insisted that 'we are entitled … and determined to defend our territorial integrity, national sovereignty and security with all force.' Iran has long insisted its nuclear program is peaceful, though it was the only non-nuclear-armed state to enrich uranium up to 60%, a short, technical step away from weapons-grade levels of 90%. The three European countries played an important role in the negotiations over the original 2015 nuclear deal between Iran and world powers. But they have repeatedly threatened to reinstate sanctions that were lifted under the deal if Iran does not improve its cooperation with the U.N. nuclear watchdog, the International Atomic Energy Agency.